High throughput screening to identify natural human monoamine oxidase B inhibitors

Phytotherapy Research

Volumn 27, Issue 6, 2013, Pages 818-828

  Mazzio, E ^a   Deiab, S ^a   Park, K ^b   Soliman, K F A ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

Author keywords

dopamine; herbs; monoamine oxidase; MPTP; natural medicine; Parkinson's

Indexed keywords

ARTEMISIA VULGARIS EXTRACT; BLACK PEPPER EXTRACT; CAESALPINIA SAPPAN EXTRACT; CARICA PAPAYA EXTRACT; CHELIDONIUM EXTRACT; CINNAMOMUM CASSIA EXTRACT; COMFREY EXTRACT; CORIANDRUM SATIVUM EXTRACT; CURCUMA LONGA EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; GREEN TEA EXTRACT; GYMNEMA SYLVESTRE EXTRACT; HUMULUS LUPULUS EXTRACT; KAVA EXTRACT; MENTHA PULEGIUM EXTRACT; MENTHA SPICATA EXTRACT; MONOAMINE OXIDASE B INHIBITOR; NATURAL PRODUCT; ORIGANUM MAJORANA EXTRACT; PAEONIA SUFFRUTICOSA EXTRACT; PHELLODENDRON AMURENSE EXTRACT; PLANT EXTRACT; PSORALEA CORYLIFOLIA EXTRACT; SALVIA OFFICINALIS EXTRACT; SAMBUCUS NIGRA EXTRACT; SELEGILINE; TANACETUM PARTHENIUM EXTRACT; TURMERIC; UNINDEXED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH THROUGHPUT SCREENING; IC 50; INSECT CELL; NONHUMAN; PROCESS DEVELOPMENT;

HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PLANT EXTRACTS; PLANTS, MEDICINAL; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

BAPTISIA; CULLEN CORYLIFOLIA; CURCUMA LONGA; CYAMOPSIS TETRAGONOLOBA; GENTIANA; GLYCYRRHIZA; LAMIACEAE; PHELLODENDRON AMURENSE; PIPER METHYSTICUM; SCUTELLARIA; SYMPHYTUM;

EID: 84878871995     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4795     Document Type: Article

References (53)

1. Anderson DG, Mariappan SV, Buettner GR, Doorn JA,. 2011. Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone. J Biol Chem 286: 26978-86.
2. Ashizawa K, Sano R,. 1990. Effects of temperature on the immobilization and the initiation of motility of spermatozoa in the male reproductive tract of the domestic fowl, Gallus domesticus. Comp Biochem Physiol A Comp Physiol 96: 297-301.
3. Chen JJ, Wilkinson JR,. 2012. The Monoamine Oxidase Type B Inhibitor Rasagiline in the Treatment of Parkinson Disease: Is Tyramine a Challenge? J Clin Pharmacol 52: 620-8.
4. Chen Y, Kong LD, Xia X, Kung HF, Zhang L,. 2005. Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the forced swimming test in mice. J Ethnopharmacol 96: 451-9.
5. Chen Y, Wang HD, Xia X, Kung HF, Pan Y, Kong LD,. 2007. Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the chronic mild stress model of depression in mice. Phytomedicine 14: 523-9.
6. Dhanik A, Sujatha N, Rai NP,. 2011. Clinical evaluation of the efficacy of Shvitrahara kashaya and lepa in vitiligo. Ayu 32: 66-9.
7. Dhingra D, Sharma A,. 2006. Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Prog Neuropsychopharmacol Bol Psychiatr 30: 449-54.
8. Drozak J, Kozlowski M,. 2006. Monoamine oxidase as a target for drug action. Postepy Hig Med Dosw (Online) 60: 498-515.
9. Fedorova NV, Tekaeva FK, Bel'gusheva ME,. 2011. The role of the MAO-B inhibitor razagiline in the treatment of Parkinson's disease. Zh Nevrol Psikhiatr Im S S Korsakova 111: 30-6.
10. Ghosh R, Graham H, Rivas P, et al,. 2010. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management. Anticancer Res 30: 857-65.
11. Gillman PK,. 2011. Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors. J Clin Psychopharmacol 31: 66-74.
12. Goren T, Adar L, Sasson N, Weiss YM,. 2010. Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline. J Clin Pharmacol 50: 1420-8.
13. Hatano T, Fukuda T, Liu YZ, Noro T, Okuda T,. 1991a. Phenolic constituents of licorice. IV. Correlation of phenolic constituents and licorice specimens from various sources, and inhibitory effects of licorice extracts on xanthine oxidase and monoamine oxidase. Yakugaku Zasshi 111: 311-21.
14. Hatano T, Fukuda T, Miyase T, Noro T, Okuda T,. 1991b. Phenolic constituents of licorice. III. Structures of glicoricone and licofuranone, and inhibitory effects of licorice constituents on monoamine oxidase. Chem Pharm Bull(Tokyo) 39: 1238-43.
15. Holt A, Palcic MM,. 2006. A peroxidase-coupled continuous absorbance plate-reader assay for flavin monoamine oxidases, copper-containing amine oxidases and related enzymes. Nat Protoc 1: 2498-505.
16. Horn PJ, Reti I, Jayaram G,. 2010. Transdermal selegiline in patients receiving electroconvulsive therapy. Psychosomatics 51: 176-8.
17. Isaacson SH,. 2010. Selective MAO-B inhibitors have low potential for the tyramine effect. Mov Disord 25: 123-4.
18. Jinsmaa Y, Florang VR, Rees JN, et al,. 2011. Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease. Chem Biol Interact 192: 118-21.
19. Kassubek J, Buttner T, Reichmann H, et al,. 2010. On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease. Fortschr Neurol Psychiatr 78 (Suppl 1): S34-6.
20. Khushboo PS, Jadhav VM, Kadam VJ, Sathe NS,. 2010. Psoralea corylifolia Linn.-"Kushtanashini". Pharmacognosy Rev 4: 69-76.
21. Kim JH, Huh JE, Baek YH, Lee JD, Choi DY, Park DS,. 2011. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes. J Ethnopharmacol 134: 234-42.
22. Kim SS, Lim J, Bang Y, et al,. in press. Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease. J Nutr Biochem.
23. Kong LD, Tan RX, Woo AY, Cheng CH,. 2001. Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders. Pharmacol Toxicol 88: 75-80.
24. Li X, Lee YJ, Kim YC, et al,. 2011. Bakuchicin induces vascular relaxation via endothelium-dependent NO-cGMP signaling. Phytother Res 25: 1574-8.
25. Lim SH, Ha TY, Kim SR, Ahn J, Park HJ, Kim S,. 2009. Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats. Br J Nutr 101: 1031-9.
26. Lin SM, Wang SW, Ho SC, Tang YL,. 2010. Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains. Nutrition 26: 1195-200.
27. Lohle M, Reichmann H,. 2011. Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease. BMC Neurol 11: 112.
28. Mallajosyula JK, Kaur D, Chinta SJ, et al,. 2008. MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology. PLoS One 3: e1616.
29. Mandel SA, Sagi Y, Amit T,. 2007. Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway. Neurochem Res 32: 1694-9.
30. Mazzio EA, Harris N, Soliman KF,. 1998. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells. Planta Med 64: 603-6.
31. Ming LG, Cheng KM, Ge BF, Ma HP, Zai YK,. 2011. Effect of isopsoralen on the proliferation and differentiate of osteoblasts in vitro. Zhong yao cai 34: 404-8.
32. Naoi M, Maruyama W,. 2009. Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease. Expert Rev Neurother 9: 1233-50.
33. Pagonabarraga J, Kulisevsky J,. 2010. Rasagiline: effectiveness and protection in Parkinson's disease. Rev Neurol 51: 535-41.
34. Polanski W, Reichmann H, Gille G,. 2011. Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-beta-carboline: a new anti-Parkinson drug? Expert Rev Neurother 11: 845-60.
35. Qiu RL, Li L, Zhu MH, Liu J,. 2011. Study on the chemical constituents of Psoralea corylifolia. Zhong yao cai = Zhongyaocai = J. Chinese Medicinal Mater 34: 1211-3.
36. Rajeswari A, Sabesan M,. 2008. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 16: 96-9.
37. Rascol O, Lozano A, Stern M, Poewe W,. 2011. Milestones in Parkinson's disease therapeutics. Mov Disord 26: 1072-82.
38. Siddiqui A, Mallajosyula JK, Rane A, Andersen JK,. 2010. Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression. Neurobiol Dis 40: 444-8.
39. Song X, Qi A, Wang Y, Jing Y, Chai X, Liu Y,. 2011. Variation of 4 kinds of compounds in Psoralea corylifolia processed by different methods. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J. Chinese Materia Medica 36: 2071-5.
40. Sultan T, Ali SA,. 2011. Psoralea corylifolia extracts stimulate cholinergic-like psoralen receptors of tadpole-tail melanophores, leading to skin darkening. J Recept Signal Transduct Res 31: 39-44.
41. Szliszka E, Skaba D, Czuba ZP, Krol W,. 2011. Inhibition of inflammatory mediators by neobavaisoflavone in activated RAW264.7 macrophages. Molecules 16: 3701-12.
42. Talati R, Reinhart K, Baker W, White CM, Coleman CI,. 2009. Pharmacologic treatment of advanced Parkinson's disease: a meta-analysis of COMT inhibitors and MAO-B inhibitors. Parkinsonism Relat Disord 15: 500-5.
43. Tanaka S, Kuwai Y, Tabata M,. 1987. Isolation of monoamine oxidase inhibitors from Glycyrrhiza uralensis roots and the structure-activity relationship. Planta Med 53: 5-8.
44. van Laar T, Boon AJ, Bloem BR,. 2010. Rasagiline is not for all Parkinson disease patients: the ADAGIO study. Ned Tijdschr Geneeskd 154: A2496.
45. Wang YH, Samoylenko V, Tekwani BL, et al,. 2010. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease. J Ethnopharmacol 128: 662-71.
46. Weinreb O, Amit T, Bar-Am O, Youdim MB,. 2010. Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity. Prog Neurobiol 92: 330-44.
47. Xian YF, Mao QQ, Ip SP, Lin ZX, Che CT,. 2011. Comparison on the anti-inflammatory effect of Cortex Phellodendri Chinensis and Cortex Phellodendri Amurensis in 12-O-tetradecanoyl-phorbol-13-acetate-induced ear edema in mice. J Ethnopharmacol 137: 1425-30.
48. Xu Q, Pan Y, Yi LT, et al,. 2008. Antidepressant-like effects of psoralen isolated from the seeds of Psoralea corylifolia in the mouse forced swimming test. Biol Pharm Bull 31: 1109-14.
49. Yang EJ, Min JS, Ku HY, et al,. 2012. Isoliquiritigenin isolated from Glycyrrhiza uralensis protects neuronal cells against glutamate-induced mitochondrial dysfunction. Biochem Biophys Res Commun 421: 658-64.
50. Yang HJ, Youn H, Seong KM, et al,. 2011. Psoralidin, a dual inhibitor of COX-2 and 5-LOX, regulates ionizing radiation (IR)-induced pulmonary inflammation. Biochem Pharmacol 82: 524-34.
51. Yi LT, Li YC, Pan Y, et al,. 2008. Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea Corylifolia in the forced swimming test in mice. Prog Neuropsychopharmacol Bol Psychiatr 32: 510-9.
52. Zhao G, Li S, Qin GW, Fei J, Guo LH,. 2007. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter. J Ethnopharmacol 112: 498-506.
53. Zhao G, Zheng XW, Qin GW, Gai Y, Jiang ZH, Guo LH,. 2009. In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of Delta 3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.). Cell Mol Life Sci 66: 1617-29.